Glenmark, Sun & Zydus recall products in US for 'manufacturing deviations'

NEW DELHI:

Drug makers Glenmark

, Sun Pharma and

Zydus

are recalling products in the US for manufacturing issues, the

US Food and Drug Administration

(USFDA) said in its latest Enforcement Report.
As per the US health regulator,

Mumbai-based Glenmark

is recalling over 25 products in the US market due to Current Good Manufacturing Practice (CGMP) deviations. A US-based subsidiary of Sun Pharma is recalling around 13,700 bottles of Gabapentin capsules, a medication used to treat seizures in people with epilepsy.